Samse SA (SAMS)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 108.50 |
|---|---|
| 52-week range | 108.50 – 134.00 |
| Return, 1 month / 3 months | −8.1% / −8.1% |
| Return, 1 year / 3 years | −9.9% / −20.0% |
| Trend | Below its 200-day average |
| RSI (14) | 15 |
| Volatility (1 year) | 20.1% |
| Worst drawdown (1 year) | -15.3% |
| Average daily value traded | 0.05M EUR |
| Dividend yield | 4.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Samse is a French distributor of building materials based in Grenoble. Through its branch network and brands such as Gedimat, it supplies timber, tools, hardware, sanitary ware and heating products. Its customers are mainly building professionals, including craftsmen and construction firms, along with individual do-it-yourself customers. The company also runs specialist operations in areas such as tool hire and timber trading, serving local markets across France.
The shares are listed on the Euronext Paris in France under the code SAMS, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Samse SA (SAMS) trades on the Euronext Paris in France. It last closed at EUR 108.50 on 23 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 154 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.9% and over the last three months it fell 8.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -7.8% | ||
| From 52-week high | -18.7% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -8.1% | ||
| 6-month return | -8.1% | ||
| 12-month return, skipping the last month | -2.0% | ||
| Stability (higher is calmer) | 90 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.3% | ||
| Liquidity | 57 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.05M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.6% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −4.8% |
|---|---|
| 1 month | −8.1% |
| 3 months | −8.1% |
| 6 months | −8.1% |
| 1 year | −9.9% |
| 3 years | −20.0% |
| 5 years | −29.6% |
Signals
| 50-day / 200-day average | 117.53 / 117.64 |
|---|---|
| Golden / death cross (60 days) | Death, 0 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.36 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Jun 2026 | EUR 5.0000 |
| 30 Jun 2025 | EUR 8.0000 |
| 20 Jun 2024 | EUR 10.0000 |
| 21 Jun 2023 | EUR 16.0000 |
| 21 Jun 2022 | EUR 16.0000 |
| 21 Jun 2021 | EUR 8.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.